Sep 10, 2013, 15:00 PM by Michael Croft

Chemical & Engineering News | As part of its 90th Anniversary issue, Chemical & Engineering News highlighted nine areas of chemistry that had a profound effect on the planet including antibiotics, computational chemistry, and structural biology.

Sep 10, 2013, 13:00 PM by Michael Croft

Xconomy | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease.

Sep 9, 2013, 14:00 PM by Michael Croft

Bloomberg Businessweek | Isis Pharmaceuticals signed a six-year agreement with Biogen Idec to develop new therapies to treat neurological disorders.

Sep 9, 2013, 13:00 PM by Michael Croft

Sep 6, 2013, 08:00 AM by Michael Croft

New Scientist | Do we have the right to ignorance? Opinions have been swirling around the disclosure aspect of genetic data, and an article in New Scientist argues that we have the right to choose ignorance.

Sep 5, 2013, 09:00 AM by Michael Croft

Bio-IT World | Natera and Illumina entered a three-year agreement yesterday dictating that Illumina will supply Natera with the HiSeq 2500 sequencing system and associated consumables for Natera’s Panorama noninvasive prenatal test (NIPT).

Sep 4, 2013, 06:00 AM by Michael Croft

Bloomberg | ImClone's Sam Waksal is making biotech plans again. Hoping to cash in on biotech's current success, Waksal is planning to spin out two units of his Kadmon Corp.

Sep 4, 2013, 06:00 AM by Michael Croft

Scientific American | Researchers at the University of Chicago have built the first biotech musical instrument. The instrument relies on proteins from plants that respond to sunlight.

Sep 3, 2013, 11:00 AM by Michael Croft

In the Pipeline | Google is always up for a long shot, and Google Ventures is backing another one. A small biotech is working on a way to orally deliver large protein drugs.

Sep 3, 2013, 07:00 AM by Michael Croft

Business Weekly | Eagle Genomics completed a funding round worth more than $926,000 (GBP 595,000). The number puts the group a bit more than halfway to its goal.

Aug 30, 2013, 09:00 AM by Michael Croft

New York Times | The Smithsonian's "Genome: Unlocking Life's Code" exhibit has been open all summer. Three months in, the New York Times looks at what has succeeded and what has fallen short in the, "smart, playful, and... enlightening" exhibit.

Aug 30, 2013, 08:00 AM by Michael Croft

Wall Street Journal Blogs | Pharma is getting more notice from venture capital these days. Clarus Ventures, for example, has backed three specific pharma projects including Phase III studies of an already-approved drug in a new indication.

Aug 30, 2013, 08:00 AM by Michael Croft

Computerworld | MIT researchers have developed a 110-core chip while looking for power-efficient ways to boost performance in mobile devices.

Aug 29, 2013, 08:00 AM by Michael Croft

Nature | It's been a great year for biotech IPOs, which has everyone wondering when the bubble will burst. In 2000 there were 26 biotech IPOs, but 2001 and 2002 showed almost no revenue from biotech IPOs.

Aug 29, 2013, 08:00 AM by Michael Croft

Forbes Asia | Forbes Asia checks in with BGI since their Complete Genomics acquisition. The group is readying an IPO of their institutional-client business, and have sequenced 57,000 human genomes to date.

Aug 28, 2013, 15:00 PM by Michael Croft

Boston Magazine | Third Rock Ventures invests heavily in biotech, now taking on projects for "ultra-orphan" diseases. Though the risks are high, the rewards are too. A recent acquisition could could net Third Rock a 20-fold payout for their investment.

Aug 28, 2013, 09:05 AM by Michael Croft

Bio-IT World | In the high north, the tiny Faroese population has been isolated—physically and genetically—for more than 1,000 years. Now the FarGen Project will be offering whole genome sequencing to all 50,000 inhabitants of the Faroe Islands.

Aug 27, 2013, 09:00 AM by Michael Croft

Bio-IT World |  A talk at the Clinical Genome Conference resonated with some folks, who suggested sharing it. Crucially, that crowd included doctors, who have much to both teach and learn in the brave new world of genomic medicine. With them on hand, the day’s session loosely echoed a grand rounds, where the case was, soberingly, the tall order of making genomes widely useful in healthcare.

Aug 26, 2013, 14:00 PM by Michael Croft

Bio-IT World | OpenBEL—the open source version of the Biological Expression Language released last June by Selventa—announced today that it is now an open source collaborative project of The Linux Foundation.

Aug 26, 2013, 09:00 AM by Michael Croft

Bio-IT World | Published in late July in GigaScience, the Assemblathon 2 paper has been in the works since June 2011. Three genomes and about 17 GB of compressed data later (doubled if you include the contig files that were extracted from the scaffolds), the findings can be summarized in five words: “We’re doing it all wrong.”